[Transcatheter closure of atrial septal defect]
B Zeevi1, M Berant, R Fogelman
1Cardiology Institute, Schneider Children's Medical Center, Petah Tikva.
Insights
Transcatheter closure offers a safe and effective alternative for treating secundum atrial septal defects (ASD). This minimally invasive approach avoids surgery, reducing recovery time and complications for pediatric patients.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Secundum atrial septal defects (ASD) are common congenital heart anomalies.
- Surgical closure, the traditional treatment, involves significant morbidity and prolonged recovery.
Purpose of the Study:
- To evaluate the safety and efficacy of transcatheter closure for secundum ASD.
- To present initial experience with the Cardioseal device for ASD occlusion.
Main Methods:
- Transcatheter closure of moderate to large central ASDs in 3 pediatric patients (ages 5-10).
- Procedures guided by fluoroscopy and transesophageal echocardiography.
- Utilized the Cardioseal device for defect occlusion.
Main Results:
- Successful transcatheter closure was achieved in all 3 patients.
- The procedure demonstrated safety and effectiveness in this initial cohort.
- This approach is suitable for approximately 60% of ASD patients.
Conclusions:
- Transcatheter closure is a viable and less invasive alternative to surgery for secundum ASD.
- The Cardioseal device shows promise for ASD occlusion in pediatric populations.
- Further research can confirm long-term outcomes and expand patient selection.
Abstract:
Isolated secundum atrial septal defect is one of the most common congenital heart defects. Surgical closure is the treatment of choice but is associated with a chest scar, some morbidity and a relatively long recovery and the use of cardiopulmonary bypass. Transcatheter closure of secundum atrial septal defect is therefore an attractive approach. 3 children, aged 5-10 years, underwent successful transcatheter closure of moderate to large central atrial septal defects with the Cardioseal device. The procedures were performed under x-ray and transesophageal echocardiographic guidance. Our initial experience, and that of others, indicates that transcatheter occlusion of secundum atrial septal defects is safe and effective and can be an appropriate alternative in approximately 60% of patients.
